Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Francisella tularensis replicates within alveolar type II epithelial cells in vitro and in vivo following inhalation.

Hall JD, Craven RR, Fuller JR, Pickles RJ, Kawula TH.

Infect Immun. 2007 Feb;75(2):1034-9. Epub 2006 Nov 6.

2.

Identification of early interactions between Francisella and the host.

Roberts LM, Tuladhar S, Steele SP, Riebe KJ, Chen CJ, Cumming RI, Seay S, Frothingham R, Sempowski GD, Kawula TH, Frelinger JA.

Infect Immun. 2014 Jun;82(6):2504-10. doi: 10.1128/IAI.01654-13. Epub 2014 Mar 31.

3.

Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection.

Gentry M, Taormina J, Pyles RB, Yeager L, Kirtley M, Popov VL, Klimpel G, Eaves-Pyles T.

Infect Immun. 2007 Aug;75(8):3969-78. Epub 2007 May 14.

4.

Control of Francisella tularensis Intracellular Growth by Pulmonary Epithelial Cells.

Maggio S, Takeda K, Stark F, Meierovics AI, Yabe I, Cowley SC.

PLoS One. 2015 Sep 17;10(9):e0138565. doi: 10.1371/journal.pone.0138565. eCollection 2015.

5.

Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112.

Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH.

Infect Immun. 2008 Dec;76(12):5843-52. doi: 10.1128/IAI.01176-08. Epub 2008 Oct 13.

6.

Francisella tularensis DeltapyrF mutants show that replication in nonmacrophages is sufficient for pathogenesis in vivo.

Horzempa J, O'Dee DM, Shanks RM, Nau GJ.

Infect Immun. 2010 Jun;78(6):2607-19. doi: 10.1128/IAI.00134-10. Epub 2010 Apr 12.

7.

Francisella tularensis has a significant extracellular phase in infected mice.

Forestal CA, Malik M, Catlett SV, Savitt AG, Benach JL, Sellati TJ, Furie MB.

J Infect Dis. 2007 Jul 1;196(1):134-7. Epub 2007 May 23.

PMID:
17538893
8.

Temporal transcriptional response during infection of type II alveolar epithelial cells with Francisella tularensis live vaccine strain (LVS) supports a general host suppression and bacterial uptake by macropinocytosis.

Bradburne CE, Verhoeven AB, Manyam GC, Chaudhry SA, Chang EL, Thach DC, Bailey CL, van Hoek ML.

J Biol Chem. 2013 Apr 12;288(15):10780-91. doi: 10.1074/jbc.M112.362178. Epub 2013 Jan 15.

9.

A Francisella tularensis locus required for spermine responsiveness is necessary for virulence.

Russo BC, Horzempa J, O'Dee DM, Schmitt DM, Brown MJ, Carlson PE Jr, Xavier RJ, Nau GJ.

Infect Immun. 2011 Sep;79(9):3665-76. doi: 10.1128/IAI.00135-11. Epub 2011 Jun 13.

10.

Invasion of erythrocytes by Francisella tularensis.

Horzempa J, O'Dee DM, Stolz DB, Franks JM, Clay D, Nau GJ.

J Infect Dis. 2011 Jul 1;204(1):51-9. doi: 10.1093/infdis/jir221.

11.

Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages.

Maier TM, Casey MS, Becker RH, Dorsey CW, Glass EM, Maltsev N, Zahrt TC, Frank DW.

Infect Immun. 2007 Nov;75(11):5376-89. Epub 2007 Aug 6.

12.

RipA, a cytoplasmic membrane protein conserved among Francisella species, is required for intracellular survival.

Fuller JR, Craven RR, Hall JD, Kijek TM, Taft-Benz S, Kawula TH.

Infect Immun. 2008 Nov;76(11):4934-43. doi: 10.1128/IAI.00475-08. Epub 2008 Sep 2.

13.

Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.

Cowley SC, Meierovics AI, Frelinger JA, Iwakura Y, Elkins KL.

J Immunol. 2010 May 15;184(10):5791-801. doi: 10.4049/jimmunol.1000362. Epub 2010 Apr 14.

14.

The use of resazurin as a novel antimicrobial agent against Francisella tularensis.

Schmitt DM, O'Dee DM, Cowan BN, Birch JW, Mazzella LK, Nau GJ, Horzempa J.

Front Cell Infect Microbiol. 2013 Dec 6;3:93. doi: 10.3389/fcimb.2013.00093. eCollection 2013.

15.

Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro.

Hazlett KR, Caldon SD, McArthur DG, Cirillo KA, Kirimanjeswara GS, Magguilli ML, Malik M, Shah A, Broderick S, Golovliov I, Metzger DW, Rajan K, Sellati TJ, Loegering DJ.

Infect Immun. 2008 Oct;76(10):4479-88. doi: 10.1128/IAI.00610-08. Epub 2008 Jul 21.

16.

Francisella tularensis invasion of lung epithelial cells.

Craven RR, Hall JD, Fuller JR, Taft-Benz S, Kawula TH.

Infect Immun. 2008 Jul;76(7):2833-42. doi: 10.1128/IAI.00043-08. Epub 2008 Apr 21.

17.

Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica.

Stenmark S, Lindgren H, Tärnvik A, Sjöstedt A.

Microb Pathog. 2003 Aug;35(2):73-80.

PMID:
12901846
18.

A method for functional trans-complementation of intracellular Francisella tularensis.

Steele S, Taft-Benz S, Kawula T.

PLoS One. 2014 Feb 4;9(2):e88194. doi: 10.1371/journal.pone.0088194. eCollection 2014.

19.

Delayed presence of alternatively activated macrophages during a Francisella tularensis infection.

D'Elia RV, Laws TR, Núñez A, Taylor C, Clark GC.

Microb Pathog. 2015 Jan;78:37-42. doi: 10.1016/j.micpath.2014.10.002. Epub 2014 Oct 2.

PMID:
25284816
20.

Francisella tularensis harvests nutrients derived via ATG5-independent autophagy to support intracellular growth.

Steele S, Brunton J, Ziehr B, Taft-Benz S, Moorman N, Kawula T.

PLoS Pathog. 2013 Aug;9(8):e1003562. doi: 10.1371/journal.ppat.1003562. Epub 2013 Aug 15.

Supplemental Content

Support Center